Transdermal Hormone Therapy – How It Works
Transdermal hormone therapy is a treatment in which hormones are delivered into the body through the skin. It is commonly used to relieve menopausal symptoms.
Things worth knowing about "Transdermal Hormone Therapy"
Transdermal hormone therapy is a treatment in which hormones are delivered into the body through the skin. It is commonly used to relieve menopausal symptoms.
What is Transdermal Hormone Therapy?
Transdermal hormone therapy (also known as transdermal hormone replacement therapy or transdermal HRT) is a method of administering hormones such as estrogen or progesterone directly through the skin. Unlike oral hormone tablets, this route of delivery bypasses the so-called hepatic first-pass effect, meaning the hormones enter the bloodstream directly without first passing through the liver. Common application forms include patches, gels, sprays, and creams.
Indications
Transdermal hormone therapy is primarily used in the following situations:
- Menopausal symptoms (climacteric): hot flushes, night sweats, sleep disturbances, mood changes, and vaginal dryness
- Osteoporosis prevention: protecting bone density from estrogen-deficiency-related bone loss
- Premature menopause or surgically induced menopause (e.g., after removal of the ovaries)
- Hypogonadism: hormone deficiency in women and men
- Gender-affirming hormone therapy: as part of a gender transition treatment plan
Mechanism of Action
When applied transdermally, hormone molecules penetrate the outer layer of the skin (the stratum corneum) and are absorbed through the capillaries in the dermis into the bloodstream. This results in steady, consistent hormone levels in the blood, avoiding the peaks and fluctuations that are typical with oral administration. Estradiol, the biologically active form of estrogen, can thus be delivered directly and effectively without prior hepatic metabolism.
Advantages Over Oral Hormone Therapy
- Bypasses the hepatic first-pass effect: reduced liver burden
- Lower risk of thromboembolic events (blood clots) compared to oral estrogens
- More stable hormone levels throughout the day
- Better tolerability for patients with gastrointestinal issues
- Convenient application and flexible dosing (e.g., adjustable gel amounts or patch sizes)
Dosage and Application
The exact dosage depends on the product used, the indication, and the individual needs of the patient, and should always be determined by a qualified healthcare professional. Typical application guidelines include:
- Patches: usually applied twice a week or once a week to clean, dry skin (e.g., abdomen or thigh)
- Gel: applied daily to a larger skin area (e.g., arms, shoulders); should be allowed to dry without rubbing
- Spray: applied to the forearm; dosage measured in pump actuations
Side Effects and Risks
As with any hormone therapy, side effects may occur with transdermal application. Common side effects include:
- Skin irritation or redness at the application site (particularly with patches)
- Breast tenderness or breast tension
- Headaches and nausea (less frequent than with oral therapy)
- Mood changes or fluid retention
More serious risks that should be discussed with a healthcare provider include:
- Increased risk of breast cancer with long-term combined estrogen-progestogen therapy
- Possible increased risk of endometrial cancer with estrogen-only therapy (in women with an intact uterus)
- Lower cardiovascular risk compared to oral therapy, but still a relevant consideration
Contraindications
Transdermal hormone therapy is not suitable for individuals with:
- Known or suspected hormone-dependent malignancies (e.g., breast cancer, endometrial cancer)
- Unexplained genital tract bleeding
- Acute thromboembolic disorders
- Severe liver disease
- Known hypersensitivity to the active ingredients or excipients
Diagnosis and Medical Supervision
Before starting transdermal hormone therapy, a comprehensive medical assessment is typically performed, including:
- Review of medical history and current symptoms
- Blood tests to measure hormone levels (e.g., FSH, LH, estradiol)
- Gynecological examination and, where appropriate, mammography
- Individual risk-benefit assessment for each patient
Regular follow-up appointments (at least once a year) are recommended during treatment to monitor therapeutic progress and identify potential risks at an early stage.
References
- Baber R. J. et al. - 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric, 2016;19(2):109–150.
- The NAMS 2022 Hormone Therapy Position Statement Advisory Panel - The 2022 hormone therapy position statement of The Menopause Society. Menopause, 2022;29(7):767–794.
- European Medicines Agency (EMA): Scientific guidelines on transdermal hormone therapy products. Available at: www.ema.europa.eu
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.